Search database
Filter
3398
Text search: drug safety
Featured
Language
Document type
1989
539
442
169
119
55
42
15
10
7
6
4
1
Countries
180
103
85
85
82
75
70
65
60
57
54
51
51
50
45
44
44
43
43
36
35
32
27
25
23
21
21
21
20
20
18
17
17
17
15
14
14
13
13
12
12
11
11
9
9
9
8
8
8
8
7
7
7
6
6
6
6
6
5
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
478
215
151
110
78
77
73
42
42
37
25
24
23
19
19
19
18
18
16
16
16
15
14
14
14
12
12
12
11
11
10
10
10
10
10
10
10
10
10
9
9
9
9
9
9
8
8
8
8
8
8
8
8
8
8
8
8
8
8
7
7
7
7
7
7
7
7
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
5
5
5
5
5
5
5
5
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
1287
347
179
152
87
51
49
2
Toolboxes
324
312
247
218
212
158
83
80
76
71
59
59
49
45
39
29
20
19
17
16
13
11
6
 Download
  View PDF
 Add to my MEDBOX

Philippine National Drug Formulary - Essential Medicines List, Volume I (7th Edition)

The National Formulary Committee, National Drug Policy, DOH Philippines (2008) C1
 Download
  View PDF
 Add to my MEDBOX

No Time to Wait: Securing the future from drug-resistant infections

IACG Interagency Coordination Group on Antimicral Resistance (2019) C_WHO
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis. If no action is taken - warns the UN Ad hoc Interagency Coordin ... more
 Download
  View PDF
 Add to my MEDBOX

No Time to Wait: Securing the future from drug-resistant infections. Summary of recommendations and key messages

IACG Interagency Coordination Group on Antimicral Resistance (2019) C_WHO
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
 Download
  View PDF
 Add to my MEDBOX

World Drug Report 2019 Booklet 1 Executive summary / Policy implications

United Nations Office on Drug and Crime UNODOC (2022) C1
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its spe ... more
 Download
  View PDF
 Add to my MEDBOX

European Drug Report 2019: trends and developments.

European Monitoring Centre for Drugs and Drug Addiction European Union (2019) C1
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as ... more
 Download
  View PDF
 Add to my MEDBOX

WHO/HIVRESNET HIV drug resistance - laboratory operational framework

World Health Organization WHO (2020) C_WHO
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping lab ... more
 Download
  View PDF
 Add to my MEDBOX

HIV drug resistance surveillance in countries scaling up pre-exposure prophylaxis

World Health Organization WHO (2020) C_WHO
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches. HIV drug resistance has been rarely ... more
 Download
  View PDF
 Add to my MEDBOX

Pretreatment drug resistance and new treatment paradigms in firstline ART

Moorhouse, M. Southern African HIV Cinicans Society (2018) C2
 Download
  View PDF
 Add to my MEDBOX

WHO manual for HIV drug resistance testing using dried blood spot specimens

World Health Organization WHO (2020) C_WHO
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middl ... more
 Add to my MEDBOX

Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010-2019)

World Health Organization WHO (2020) C_WHO
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies o ... more
 External Link
 Add to my MEDBOX

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Polack, F.P. et al. (2020) CC
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
 External Link
 Add to my MEDBOX

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Logunov, D.Y, et al. (2021) C1
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
 Add to my MEDBOX

Global vaccine safety blueprint 2.0 (GVSB2.0) 2021-2023

World Health Organization WHO (2022) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Basic occupational safety and health for respiratory diseases

The Union (2021) C1
A desk guide for health facilities . It outlines a comprehensive approach to respiratory health, which health facilities can adapt and implement in resource-limited settings
 Add to my MEDBOX

Quality and safety practices for malaria rapid testing services

World Health Organization WHO (2022) C_WHO
This document is a guide defining requirements for quality and safety for malaria rapid diagnostic testing services to safeguard the quality of the results, the safety of the operators and patients ... more
 Download
  View PDF
 Add to my MEDBOX

Zika virus and safety of substances of human origin – A guide for preparedness activities in Europe

European Centre for Disease Prevention and Control (2016) CC
The objective of this document is to guide the preparation and implementation of national preparedness plans for the safety of substances of human origin during outbreaks of Zika virus infection, both in affected and non-affected areas.
 External Link
 Add to my MEDBOX

Evaluation of drug promotional materials in a hospital setting in Nepal

Alam K., Shah A.K., Ojah P., et al. Southern Med Review (2009) C1
Southern Med Review (2009)2;1:2-6
 Download
  View PDF
 Add to my MEDBOX

Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended

World Health Organization WHO (2017) C_WHO
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an ... more
 Download
  View PDF
 Add to my MEDBOX

Field Guide for the Management of Drug-Resistant Tuberculosis
recommended

A. Piubello The International Union Against Tuberculosis and Lung Disease (2018)
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the use of delamanid in the treatment of drug-resistant TB in India
recommended

Ministry of Health & Family Welfare, India; World Health Organization (WHO) (2018) C1
 Download
  View PDF
 Add to my MEDBOX

Community-Based Care for Drug-Resistant Tuberculosis: A Guide for Implementers

United States Agency for International Development (USAID) (2011)
This guide provides practical, step-by-step guidance on how to organize, implement, and monitor community-based care for DR TB. It is equally useful for program planning or supervision. The target audience for this guide is TB Program Managers, governments, policy makers, nongovernmental organizatio ... more
 Add to my MEDBOX

WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings
recommended

World Health Organization (2016) C_WHO
 External Link
 Add to my MEDBOX

Operational Guidelines for the Management of Drug Resistant TB in Tanzania
recommended

Ministry of Health and Social Welfare, The United Republic of Tanzania (2012) C1
NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME
 Download
  View PDF
 Add to my MEDBOX

Occupational health and safety policy and guidelines for the health sector

Ministry of Health Ghana; Ghana Health Service Ghana (2010) C1
 Add to my MEDBOX

Report National Tuberculosis Drug Resistance Survey, 2006-2007

National Center for TB and Leprosy Control (CENAT) , Cambodia (2011) CC
 Download
  View PDF
 Add to my MEDBOX

Anti-Malarial Drug Resistance in Cameroon

The Cameroon Academy of Sciences (2013) CC
 Download
  View PDF
 Add to my MEDBOX

Guidelines on programmatic management of drug resistant tuberculosis in Ethiopia
recommended

Ministry of Health Ethiopia (2014) CC
2nd edition
 Download
  View PDF
 Add to my MEDBOX

Double Trouble: Injection Drug Use and Sexual Behaviour

Bhattacharya A, et al. India HIVAIDS Alliance; Hridaya Harm Reduction in India (2015) C1
Findings from a cross-sectional qualitative study of HIV vulnerabilities among People Who Inject Drugs and their sex partners in Bihar and Manipur, India. The study is one of the first qualitative comparative studies to seek an in-depth understanding of the vulnerabilities to HIV acquisition among P ... more
 Add to my MEDBOX

National Policy on Injection Safety and Medical Waste Management

Ministry of Health, Kenya (2017) C1
 Download
  View PDF
 Add to my MEDBOX

Liberia National Drug Policy 2001

Ministry of Health and Social Welfare, Liberia (2010) C1
 Download
  View PDF
 Add to my MEDBOX

Drugs and Drug Control in Namibia

Kazembe, L.N. & Neema, I. (2015) C2
 Download
  View PDF
 Add to my MEDBOX

Policy Implementation Package for new TB drug introduction (Russian version)

World Health Organization Europe Всемирная организация здравоохранения (2014) C_WHO
ПАКЕТ МЕР ПО РЕАЛИЗАЦИИ ПОЛИТИКИ В ОТНОШЕНИИ ВНЕДРЕНИЯ НОВЫХ ПРОТИВОТУБЕРКУЛЕЗНЫХ ПРЕПАРАТОВ
 Download
  View PDF
 Add to my MEDBOX

Rwanda: Country profile: Violence and injuries - Road safety

World Health Organization (WHO) (2015) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Helping someone with drug use problems

Mental Health First Aid (Australia) (2019) C2
Mental Health First Aid Guidelines Accessed: 14.03.2019
 Download
  View PDF
 Add to my MEDBOX

Prevention of Drug Use and Treatment of Drug Use Disorders in Rural Settings
recommended

United Nations Office on Drug and Crime UNODC (2017) C1
 Download
  View PDF
 Add to my MEDBOX

International Standards of Drug Use Prevention

World Health Organization (WHO); United Nations Office on Drug and Crime UNODC (2019) C_WHO
2nd revised edition. Accessed Apri. 17, 2019 Prevention strategies based on scientific evidence working with families, schools, and communities can ensure that children and youth, especially the most marginalized and poor, grow and stay healthy and safe into adulthood and old age. For every dollar ... more
 Download
  View PDF
 Add to my MEDBOX

FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis

TB Alliance (2019) CC
 Add to my MEDBOX

Considerations for introducing new antiretroviral drug formulations for children

World Health Organization WHO (2020) CC
Policy brief. July 2020
 Download
  View PDF
 Add to my MEDBOX

WHO recommendations on drug treatment for non-severe hypertension in pregnancy
recommended

World Health Organization WHO (2020) C_WHO
The primary audience of these recommendations includes healthcare providers who are responsible for developing national and local health protocols (particularly those related to hypertensive disorders of pregnancy), and those directly providing care to pregnant women and their newborns, including mi ... more
 Add to my MEDBOX

Nursing Guide for Managing Side Effectsto Drug-resistant TB Treatment

Raftery A, Tudor C, True L, Navarro C (2018) C1
The guide is organized into the major types of toxicities, the associated symp-toms, possible offending medications, and the suggested nursing assessments and interventions. Some symptoms (e.g. nausea) may be associated with a num-ber of underlying causes and may be mild, or a symptom of ... more
 Download
  View PDF
 Add to my MEDBOX

Covid-19 vaccines: safety surveillance manual. Module on safety surveillance of COVID-19 vaccines in pregnant and breastfeeding women

World Health Organization WHO (2020) C_WHO
13 July 2021 The module provides an overview of factors to consider when monitoring the safety of COVID-19 vaccines administered to pregnant and breastfeeding women. It describes how national routine AEFI surveillance should be adapted to cater fo ... more
 Download
  View PDF
 Add to my MEDBOX

WHO guideline: the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health care settings

World Health Organization WHO (2016) C_WHO
Injection practices worldwide and especially in low- and middle-income countries (LMICs) include multiple, avoidable unsafe practices that ultimately lead to the large-scale transmission of bloodborne viruses among patients, health care providers and the community at large.
 Download
  View PDF
 Add to my MEDBOX

International standards for the treatment of drug use disorders - Revised Edition Incorporating Results Of Field - Testing

World Health Organization WHO (2020) C_WHO
This document is based on currently available scientific evidence on treatment for drug use disorders and sets out a framework for the implementation of the Standards, in line with principles of public health care. The Standards identify major compo ... more
 External Link
 Add to my MEDBOX

Influence of Burnout on Patient Safety: Systematic Review and Meta-Analysis

Garcia C., Abreu L., Ramos J. , et al. (2019) CC
Medicina 2019, 55, 553; doi:10.3390/medicina55090553 Results: Twenty-one studies were analyzed, most of them demonstrating an association between the existence of burnout and the worsening of patient safety. High levels of burnout is more common am ... more
 Download
  View PDF
 Add to my MEDBOX

Caring for those who care. Guide for the development and implementation of occupational health and safety programmes for health workers

World Health Organization WHO; ILO (2022) C_WHO
Occupational health and safety programmes aim to prevent diseases and injuries arising out of, linked with or occurring in the course of work, while improving the quality and safety of care, safegua ... more
 Download
  View PDF
 Add to my MEDBOX

Preferred Practices for Zithromax® Mass Drug Administration

International Coalition for Trachoma Control ICTC (2013) CC
Countries, partners, and donors are committed to the global elimination of blinding trachoma by 2020. Achieving this public health milestone requires more than funding; it requires health personnel with the right mix of skills, and well supported and managed health systems. Mass ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the programmatic management of drug-resistant tuberculosis

World Health Organization (2011) C_WHO
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response to the Sixty-second World Health Assembly’s resolution on prevention an ... more
 Download
  View PDF
 Add to my MEDBOX

Guidelines for the Management of Adverse Drug Effects of Antimycobacterial Agents

Lawrence Flick Memorial Tuberculosis Clinic, Philadelphia Tuberculosis Control Program (1998) C2
 Download
  View PDF
 Add to my MEDBOX

Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation

European Monitoring Centre for Drugs and Drug Addiction (2018) C2
An update from the EU Early Warning System
 Download
  View PDF
 Add to my MEDBOX

Approaches for mobile and migrant populations in the context of malaria multi-drug resistance and malaria elimination in the Greater Mekong Subregion

World Health Organization ( WHO), Regional Office for South-East-Asia (2016) C_WHO
The emergence of multifrug-resistant malaria in the Greater Mekong Subregion (‎GMS)‎ has been identified as an emergency issue that may have catastrophic consequences on the future of malaria elimination in the GMS as well as globally. In recognition of the need for a cohesive regional response, ... more
 Add to my MEDBOX

Guidelines for Clinical and Operational Management of Drug-Resistant Tuberculosis

José A. Caminero International Union Against Tuberculosis and Lung Disease (The Union) (2013)
 Download
  View PDF
 Add to my MEDBOX

Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India + Annexures

Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare (2012) C1
 Download
  View PDF
 Add to my MEDBOX

Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India

Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare, Nirman Bhavan (2012) CC
Revised National Tuberculosis Control Programme
 Add to my MEDBOX

Guidelines for the Management of Drug Resistant Tuberculosis in Kenya

Ministry of Public Health and Sanitation, Kenya (2010) CC
 Add to my MEDBOX

Building Local Coalitions for containing drug resistance: A guide

USAID, Strengthening Pharmaceutical Systems SPS (2011) C1
 External Link
 Add to my MEDBOX

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review

G. B. Migliori, E. Pontali, G. Sotgiu, et al. International Journal of Molecular Scienes (2017) C2
Int. J. Mol. Sci. 2017, 18, 341, 1 - 10
 Download
  View PDF
 Add to my MEDBOX

Strengthening and aligning diagnosis and treatment of drug-resistant TB in Russian Federation

I. A. Vasilyeva Russian Ministry of Health (2017) C1
Accessed November 2017
 Download
  View PDF
 Add to my MEDBOX

Expansion Plan of Programmatic Management of Drug Resistant TB (PMDT)

National TB Control Programme, Bangladesh World Health Organization WHO, Bangladesh (2013) C1
 Download
  View PDF
 Add to my MEDBOX

International Standards for the Treatment of Drug Use Disorders
recommended

World Health Organization, United Nations Office on Drugs and Crime (2017) C2
 Download
  View PDF
 Add to my MEDBOX

Vietnam: National Action Plan on Combating Drug Resistance in the period from 2013 - 2020

Ministry of Health Vietnam (2013) C2
In Vietnam, most of the examination and treatment facilities are facing with of spread of bacteria resistant to many antibiotics. The level and speed of drug resistance are increasing, at alarming level. The burden of ... more
 Download
  View PDF
 Add to my MEDBOX

Communication in Crises Related to Vaccine Safety: Technical Guidance

Pan American Health Organisation PAHO (2021) C_WHO
3 February 2021 Vaccine- and vaccination-related crises require a communication response that is different from the communication strategies used to promote the benefits and importance of vaccines in general. This document presents the technical guidance needed to develop a communication plan that ... more
 Download
  View PDF
 Add to my MEDBOX

Rapid Communication: Key changes to the treatment of drug-resistant tuberculosis
recommended

World Health Organization WHO (2022) C_WHO
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB. This Ra ... more
 Download
  View PDF
 Add to my MEDBOX

COVID-19 Guidelines Module 5 - Drug therapy

National Department of Health, South Africa NDoH South Africa (2021) CC
 Download
  View PDF
 Add to my MEDBOX

DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended

Médecins sans Frontières (2016) C_WHO
4th edition. This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of ... more
 Download
  View PDF
 Add to my MEDBOX

Keep Safe - Keep Serving. Standard Safety Measures for Health Worker
recommended

World Health Organization; Christian Health Association Liberia (2014)
Reproduced by CHAL (Chrisitan Health Association Liberia) 3 October 2014
 Download
  View PDF
 Add to my MEDBOX

Updated Guidelines for Prevention of Parent to Child Transmission (PPTCT) of HIV using Multi Drug Anti-retroviral Regimen in India

NACO (2013)
 Download
  View PDF
 Add to my MEDBOX

TIP 18: The Tuberculosis Epidemic: Legal and Ethical Issues for Alcohol and Other Drug Treatment Providers: Treatment Improvement Protocol (TIP) Series 18

D. H. Mulligan, U.S Department of health and human service (1995) C2
 Download
  View PDF
 Add to my MEDBOX

Infection prevention, control and surveillance: Limiting the development and spread of drug-resistance

O’Neill, J. Review on Antimicrobial Resistance (2016) C1
 Download
  View PDF
 Add to my MEDBOX

National Guidelines and Operational Manual for Programmatic Management of Drug Resistant TB (PMDT), 2nd ed.

Government of the People’s Republic of Bangladesh, Directorate General of Health Services (2013) C1
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of ... more
 Download
  View PDF
 Add to my MEDBOX

Harsh punishment - The Human Toll of Georgia’s Abusive Drug Policies

G. Gogia Human Rights Watch (2018) C2
 External Link
 Add to my MEDBOX

Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon

G. F. Tchouwa; , S. Eymard-Duvernay; A. Cournil; et al. Elsevier; E Clinical Medecine (Published by the Lancet) (2018) C2
EClinicalMedicine 1 (2018) 21–27 https://doi.org/10.1016/j.eclinm.2018.06.005 2589-5370/© 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). EClinicalMedicine: journal homepage: https://www.jo ... more
 Download
  View PDF
 Add to my MEDBOX

WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-resistant tuberculosis treatment,update

World Health Organization WHO (2022) C_WHO
These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on ... more
 Add to my MEDBOX

Multiple first-line therapies as part of the response to antimalarial drug resistance

World Health Organization WHO (2024) C_WHO
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner ... more
 Download
  View PDF
 Add to my MEDBOX

WHO treatment guidelines for isoniazid-resistant tuberculosis: Supplement to the WHO treatment guidelines for drug-resistant tuberculosis
recommended

World Health Organization WHO (2018) C_WHO
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
 Download
  View PDF
 Add to my MEDBOX

TB Guidelines for Nurses in the Care and Control of Tuberculosis and Multi-drug Resistant Tuberculosis

International Council of Nurses (2015) C2
3rd edition.
 Download
  View PDF
 Add to my MEDBOX

Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis

World Health Organization (2017) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Good Practices in strengthening health systems for the prevention and care of Tuberculosis and drug-resistant Tuberculosis

World Health Organization, Europe (2016) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Strategic plan for the prevention and control of multidrug-resistant and extensively drug-resistant tuberculosis in the Eastern Mediterranean Region (2010–2015)

World Health Organization Eastern Mediterranean (2010) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis

World Health Organization WHO (2021) CC
Meeting Report 27-29 October 2020 The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this ... more
 Add to my MEDBOX

Diagnostic test for lymphatic filariasis to support decisions for stopping triple-therapy mass drug administration: target product profile

World Health Organization WHO (2021) C_WHO
TARGET PRODUCT PROFILE
 Download
  View PDF
 Add to my MEDBOX

Bad Bug Book

Food and Drug Administration (FDA) (2013)
Handbook of Foodborne Pathogenic Microorganisms and Natural Toxins
 Download
  View PDF
 Add to my MEDBOX

Uganda: Annual Pharmacovigilance Report July 2015 – June 2016

National Drug Authority, Uganda (2016) C1
 Download
  View PDF
 Add to my MEDBOX

WHO Guidelines for treatment of Drug-susceptible TB and patient Care

World Health Organization (2017) C_WHO
 Add to my MEDBOX

Formulary of Narcotic Drugs and Psychotropic Substances for Ethiopia

Drug Administration and Control Authority (DACA) of Ethiopia (2004) C1
 Download
  View PDF
 Add to my MEDBOX

The Wise List 2015

Stockholm Drug and Therapeutics Committee (2015) C_WHO
with recommended essential medicines for common diseases in patients in Stockholm County Council (Healthcare Region), Sweden
 Download
  View PDF
 Add to my MEDBOX

Ethiopia: Standard Treatment Guidelines for Health Center

Drug Administration and Control Authority of Ethiopia Contents (2014) C1
3rd edition
 Download
  View PDF
 Add to my MEDBOX

Uganda: Guidelines on good manufacturing practice for medicinal products - Part 1

National Drug Authority (NDA), Uganda (2017) C2
 Download
  View PDF
 Add to my MEDBOX

SSI Prevention - CORRECT AND SAFE SURGICAL ANTIBIOTIC PROPHYLAXIS

Surgical Unit-based Safety Program World Health Organisation (WHO) (2018) C_WHO
 Download
  View PDF
 Add to my MEDBOX

Role of sterile injection equipment and outreach programmes for injecting drug users

World Health Organization (2012) C_WHO
Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related harm? Is advice on ways to reduce drug related harm safe and effective, using an outreach mode ... more
 Add to my MEDBOX

Risk management Plan Guideline for COVID-19 Vaccines

Ethiopian Food and Drug Authority (2021) CC
July 2021
 Download
  View PDF
 Add to my MEDBOX

Guidelines for Good Clinical Practice (GCP) for Trials on Pharmaceutical Products Bangladesh

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh (2015) C1
 Download
  View PDF
 Add to my MEDBOX

Registration Guidelines for Medical Devices Bangladesh 2015

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh (2015) C1
 Download
  View PDF
 Add to my MEDBOX

Instructions for Completing Suspected Adverse Event Reporting Form

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh (2014) C1
 Download
  View PDF
 Add to my MEDBOX

Quality Manual

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh (2012) C1
 Download
  View PDF
 Add to my MEDBOX

Uganda: Guidelines on good manufacturing practice for medicinal products - ANNEXES

National Drug Authority (NDA), Uganda (2017) C1
Doc. No.: INS/GDL/001-(Annexes)
 Download
  View PDF
 Add to my MEDBOX

Women speak out: understanding women who inject drugs in Indonesia

Indonesian Drug Users Network (2016) C1
 Download
  View PDF
 Add to my MEDBOX

Diagnostics Catalog August 2018

Global Drug Facility World Health Organization WHO, Stop TB (2018) C_WHO
Stop TB`s GDF provides a wide range of diagnostic equipment and laboratory supplies in its Diagnostics Catalog
 Download
  View PDF
 Add to my MEDBOX

Medicines Catalog August 2018

Global Drug Facility World Health Organization WHO, Stop TB (2018) C_WHO
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
 Download
  View PDF
 Add to my MEDBOX

Executive Summary - Conclusions and policy implications

United Nations Office on Drugs and Crime; World Drug Report 2017 (2019) C2
World Drug Report 2017 -1- Accessed: 14.03.2019
 Download
  View PDF
 Add to my MEDBOX

List of Registered Medical Device for Import

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh (2017) C1